fda drug shortage list semaglutide status january 2025 declares end to Wegovy and Ozempic GLP-1 No Longer on FDA's – As of February 21, 2025,

For 503A pharmacies, FDA reiterated a limited enforcement policy from its 2018 guidance, Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: the agency does not intend to take action where a compounder fills four or fewer prescriptions per calendar month of a drug that is essentially a copy of a commercially available drug

Still, if 30G and 29G are both available at similar cost, 30G is the better choice

7 minutes

Read On Demystifying GLP1 Face Demystifying GLP Face: What Happens to Your Face WhenYou Lose Weight Fast

June 30, 2026 Scale your patent expertise &AI is a platform for patent litigators to craft trial-ready work productfast enough for pitches, strong enough for court.

We use the SECA scale to get baseline measurements and will continue using the scale throughout treatment to track your progress